Steris | STE - Ebitda


Steris reported $443M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
3M USD 2.22B 566M Sep/2026
Accuray USD -685K 900K Sep/2024
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
CONMED USD 78.12M 21.73M Jun/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Dexcom USD 388.7M 24.2M Jun/2026
Ecolab USD 898.5M 144.8M Mar/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Fortive USD 323.4M 9.4M Jun/2026
Getinge SEK 1.89B 1.58B Jun/2026
Globus Medical USD 279.84M 48.01M Jun/2026
Haemonetics USD 96.17M 91.87M Jun/2026
Idexx Laboratories USD 468.46M 67.59M Jun/2026
Insulet USD 199.8M 18.1M Jun/2026
Integra LifeSciences USD 79.79M 1.37M Sep/2026
Intuitive Surgical USD 1.2B 147.7M Jun/2026
J&J USD 8.99B 721M Jun/2026
Olympus JPY 46.26B 2.85B Jun/2026
Orthofix International USD 27.88M 2.77M Dec/2025
Owens Minor USD 90.02M 2.15M Dec/2025
ResMed USD 559.78M 9.06M Jun/2026
Steris USD 443M 48.3M Mar/2026
Stryker USD 1.93B 357M Jun/2026
Tandem Diabetes Care USD 6.42M 3.69M Jun/2026
Teleflex USD 122.91M 47.28M Jun/2026
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
Zimmer Biomet Holdings USD 830.5M 190.4M Jun/2026